IRIS
CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.970
AS - Asia 6.573
NA - Nord America 4.187
SA - Sud America 1.486
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 24.333
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.965
US - Stati Uniti d'America 4.082
SG - Singapore 2.238
IE - Irlanda 1.306
BR - Brasile 1.209
CN - Cina 1.190
VN - Vietnam 1.173
HK - Hong Kong 1.070
IT - Italia 415
GB - Regno Unito 410
KR - Corea 345
DE - Germania 285
GR - Grecia 173
IN - India 168
AR - Argentina 110
FR - Francia 77
FI - Finlandia 61
JP - Giappone 60
ID - Indonesia 51
EC - Ecuador 49
BD - Bangladesh 47
SE - Svezia 46
MX - Messico 42
UA - Ucraina 38
TR - Turchia 37
CA - Canada 34
ZA - Sudafrica 34
AT - Austria 30
CO - Colombia 30
PL - Polonia 30
NL - Olanda 28
IQ - Iraq 25
ES - Italia 24
PK - Pakistan 24
PY - Paraguay 21
MA - Marocco 19
UZ - Uzbekistan 19
VE - Venezuela 19
BE - Belgio 18
PE - Perù 17
EG - Egitto 15
TH - Thailandia 15
CL - Cile 12
CZ - Repubblica Ceca 12
KE - Kenya 12
DZ - Algeria 11
AE - Emirati Arabi Uniti 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
CH - Svizzera 9
TW - Taiwan 9
UY - Uruguay 9
AZ - Azerbaigian 8
BO - Bolivia 8
JM - Giamaica 8
JO - Giordania 7
MY - Malesia 7
NP - Nepal 7
PH - Filippine 7
RS - Serbia 7
OM - Oman 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
IL - Israele 4
MK - Macedonia 4
PT - Portogallo 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
Totale 24.317
Salva come PNG Salva come JPEG
Città #
Moscow 3.132
Dublin 1.305
Hong Kong 1.033
Santa Clara 1.023
Singapore 928
Jacksonville 399
Ho Chi Minh City 394
Seoul 341
San Jose 294
Hanoi 282
Hefei 257
Ashburn 226
Princeton 187
Roxbury 187
Chandler 176
Beijing 168
Medford 140
Bremen 121
Naples 91
Bengaluru 90
São Paulo 89
Da Nang 76
Los Angeles 68
New York 68
Des Moines 63
Dallas 53
Ann Arbor 51
Cambridge 50
Boardman 47
Munich 46
The Dalles 44
Council Bluffs 41
Haiphong 41
Wilmington 41
Jinan 37
Rio de Janeiro 35
Rome 35
Nanjing 28
Falkenstein 25
Nuremberg 25
Belo Horizonte 24
Biên Hòa 24
Curitiba 24
Guarulhos 23
Turku 23
Boston 21
Chennai 21
Hải Dương 21
Atlanta 20
Dearborn 20
Guayaquil 20
Tokyo 20
Brasília 19
Porto Alegre 19
Frankfurt am Main 18
Guangzhou 18
Bắc Ninh 17
Ninh Bình 17
Orem 17
Tashkent 17
Campinas 16
Hebei 16
Helsinki 16
Johannesburg 16
Lappeenranta 16
Warsaw 16
Amsterdam 15
Buenos Aires 15
Shanghai 15
Shenyang 15
Brussels 14
Caserta 14
Vũng Tàu 14
Bangkok 13
Jakarta 13
London 13
Phủ Lý 13
Salvador 13
Vienna 13
Can Tho 12
Goiânia 12
Milan 12
Palermo 12
Thái Bình 12
Bến Tre 11
Hillsboro 11
Mexico City 11
Norwalk 11
Ribeirão Preto 11
Thái Nguyên 11
Tianjin 11
Huế 10
Lima 10
Montreal 10
Redwood City 10
São Gonçalo 10
São José dos Campos 10
Bogotá 9
Brno 9
Casablanca 9
Totale 12.640
Salva come PNG Salva come JPEG
Nome #
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? 192
An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia 171
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 163
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 150
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 146
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 141
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis 137
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 136
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 134
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 130
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab 129
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 129
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 126
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 125
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 125
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 125
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome 124
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 124
CD8+tissue-resident memory T cells are expanded in primary Sjögren’s disease and can be therapeutically targeted by CD103 blockade 123
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease 122
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 121
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 119
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 119
Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery 118
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 116
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 116
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 116
Adult-onset Still's disease with elderly onset: results from a multicentre study 116
IL-23 OVEREXPRESSION AS IMMUNOLOGICAL SIGNATURE OF SUBCLINICAL INTESTINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS 115
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 114
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 114
Precision medicine in systemic lupus erythematosus 114
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 114
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 114
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 114
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 113
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 112
ILC3 in Axial Spondyloarthritis: the Gut Angle 111
New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine? 110
Gut dysbiosis in Spondyloarthritis: Cause or effect? 110
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity 110
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 109
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity 109
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 108
Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease 107
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 107
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-Associated spondyloarthritis 107
JAK/STAT Pathway Targeting in Primary Sjögren Syndrome 107
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 106
Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 106
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort 105
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 105
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 104
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 102
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 102
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 102
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 101
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 101
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity 101
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 100
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 100
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 100
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 100
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 100
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 99
null 99
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 99
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 99
Short-Facelift Approach in Temporal Artery Biopsy: Is It Safe? 98
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis 98
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database 97
The gut-enthesis axis and the pathogenesis of Spondyloarthritis 97
The craniovertebral junction in rheumatoid arthritis: State of the art 97
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 97
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 96
Intestinal Involvement in Kawasaki Disease 96
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis 96
Interstitial lung disease in systemic sclerosis: current and future treatment 96
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis 96
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 96
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 95
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 95
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 95
The Cross-Talk between Microbiome and Metabolome in Rheumatoid Arthritis 95
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 95
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 95
Cardiovascular disease in primary sjögren’s syndrome 95
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 94
Gut inflammation in spondyloarthritis 94
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 93
IVIG in APS pregnancy 93
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 93
Autophagy in the pathogenesis of ankylosing spondylitis 93
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 93
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 92
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 92
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 92
The bone marrow side of axial spondyloarthritis 91
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 91
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 91
Totale 10.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 0 0 0 0 16 181 8
2021/20221.010 21 11 1 24 372 4 37 16 48 28 66 382
2022/20231.724 246 12 26 17 208 59 4 60 1.020 5 43 24
2023/20241.032 35 30 39 55 368 101 27 29 11 7 57 273
2024/20254.236 14 45 9 88 646 518 478 439 537 940 304 218
2025/202615.547 545 866 894 963 1.266 8.304 1.231 582 674 222 0 0
Totale 24.908